Dental Soft Tissue Regeneration Market - Global Forecast to 2029
商品番号 : SMB-70022
| 出版社 | MarketsandMarkets |
| 出版年月 | 2024年11月 |
| ページ数 | 226 |
| 図表数 | 253 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The dental soft-tissue regeneration market is projected to reach USD 0.54 billion by 2029 from USD 0.37 billion in 2024, at a CAGR of 7.8% during the forecast period.
歯科用軟部組織再生市場は、予測期間中のCAGR 7.8%で、2024年の3億7,000万米ドルから2029年までに5億4,000万米ドルに達すると予測されています。
The dental soft-tissue regeneration market has had strong growth due to a number of factors such as the rising incidences of periodontal diseases, increasing awareness of oral health, and growing trend of cosmetic dentistry. Moreover, the initіatіves tо dеvеlop healthcarе infrаstructure іn underdеvеlopеd regions demand morе dental treatments and related products. Additionally, the advancements in regenerative biomaterials has also played a major role in the market’s growth.
“By product type, collagen-based segment is expected to have the largest market share in the dental soft-tissue regeneration market.”
Based on the product type, the collagen-based membrane segment is expected to dominate the the dental soft-tissue regeneration market due to several factors. Collagen-based membranes acts as barriers to guide tissue growth, where they support the healing of periodontal defects and implant-based defects. Moreover, these membrnes have the ability to integrate with surrounding tissues and supports the growth of new connective tissue. Furthermore, innovations in regenerative biomaterials further support the growth of this market.
“By application, implantology segment is expected to have the largest market share in the dental soft-tissue regeneration market.”
Based on application, the implantology segment is expected to hold the largest market share in the dental soft-tissue regeneration market due to the growing aging population, increasing awareness of oral health and increasing demand for cosmetic dentistry. Moreover, to promote healing in peri-implant soft tissues, products like collagen membranes, soft tissue grafts, and advanced bioactive materials are increasingly used. Additionally, innovations in soft tissue regenerative solutions, and increasing awareness of dental aesthetics further support the growth of dental soft-tissue regeneration market.
“By region, North American region is expected to have the largest market share in the dental soft-tissue regeneration market.”
North America to register for the highest share of the dental soft-tissue regeneration market during the forecast period due to several factors. The presence of advanced healthcare infrastructure, and high health expenditure rates drive the demand for advanced dental care treatments in this region. Moreover, the significant rise in the geriatric population, which is more prone to periodontal diseases, covers the majority of the treatments required in North America. Favorable government policies, and reimbursement frameworks for dental care treatments, along with a high dental insurance coverage among the patients, supports them toward getting advance dental care treatments. Additonaly, the ongoing research and development in dental technologies and biomaterials, also support this expansion in this region.
A breakdown of the primary participants (supply-side) for the dental soft-tissue regeneration market referred to for this report is provided below:
- By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25%
- By Designation: C-level–45%, Director Level–35%, and Others–20%
- By Region: North America–27%, Europe–25%, Asia Pacific–30%, Latin America- 8%, Middle East & Africa-10% .
Prominent players in the dental soft-tissue regeneration market are Geistlich Pharma AG (Switzerland), Dentsply Sirona (US), Institut Straumann AG (Switzerland), Zimvie Inc. (US), Henry Schein, Inc. (US), AbbVie Inc. (US), Advanced Medical Solutions Group Plc (UK), Tissue Regenix (UK), Septodont Holding (France), Medical Consult Implants GmbH (Germany), Meccellis (US), Regedent Ag (Switzerland), Regenity (US), Envista (US), AD Surgical (US), LifeNet Health (US), B. & B. Dental S.R.L. (Italy), Alpha-Bio Tec. Ltd. (Israel), Lasak S.R.O. (Czechia), KeystoneDentalGroup (US), Neoss AG (Switzerland), Bego GmbH Co. KG (Germany), Biotech Dental (France), Samyang Holdings Corporation (South Korea), and RTI Surgical (US).
Research Coverage:
The report analyzes the dental soft-tissue regeneration market and aims at estimating the market size and future growth potential of this market based on various segments such as product type, application, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall dental soft-tissue regeneration market. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (rising prevalence of periodontal diseases, rising awareness and growing demand for cosmetic dentistry, advancements in biomaterials, and advancements in regenerative technology), restraints (inadequate reimbursement and high cost of dental services, and dearth of trained dental practitioners), opportunities (consolidation of dental practices and rising DSO activity, growing focus on emerging economies and rising disposable income levels, and growing dental tourism in emerging countries) and challenges (pricing pressure faced by prominent market players, and stringent regulatory environment).
- Market Penetration: It includes extensive information on products offered by the major players in the global the dental soft-tissue regeneration market. The report includes various segments in product type, application, end user and region.
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global dental soft-tissue regeneration market.
- Market Development: Thorough knowledge and analysis of the profitable rising markets by type, application, end user and region.
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the dental soft-tissue regeneration market.
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global dental soft-tissue regeneration market.
Table of Contents
1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
1.3 STUDY SCOPE 24
1.3.1 SEGMENTS CONSIDERED 24
1.3.2 INCLUSIONS & EXCLUSIONS 25
1.3.3 YEARS CONSIDERED 25
1.3.4 CURRENCY CONSIDERED 26
1.4 STAKEHOLDERS 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
2.1.1 SECONDARY DATA 27
2.1.1.1 Key sources for secondary research 28
2.1.1.2 Key data from secondary sources 29
2.1.2 PRIMARY DATA 29
2.1.2.1 Objectives of primary research 30
2.1.2.2 Key data from primary sources 30
2.1.2.3 Key industry insights 31
2.1.2.4 Breakdown of primaries 31
2.2 MARKET SIZE ESTIMATION 33
2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 33
2.2.2 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 34
2.2.3 TOP-DOWN APPROACH: SUPPLY-SIDE ANALYSIS 36
2.3 DATA TRIANGULATION 39
2.4 MARKET SHARE ESTIMATION 40
2.5 STUDY ASSUMPTIONS 40
2.6 RESEARCH LIMITATIONS 41
2.7 RISK ASSESSMENT 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 45
4.1 DENTAL SOFT-TISSUE REGENERATION MARKET OVERVIEW 45
4.2 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE AND COUNTRY (2023) 46
4.3 DENTAL SOFT-TISSUE REGENERATION MARKET: REGIONAL MIX 47
4.4 DENTAL SOFT-TISSUE REGENERATION MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 47
4.5 DENTAL SOFT-TISSUE REGENERATION MARKET: EMERGING VS. DEVELOPED MARKETS 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
5.2.1 DRIVERS 50
5.2.1.1 Rising prevalence of periodontal diseases 50
5.2.1.2 Growing demand for cosmetic dentistry 50
5.2.1.3 Rising popularity of biodegradable biomaterials 51
5.2.1.4 Advancements in regenerative technologies 51
5.2.2 RESTRAINTS 52
5.2.2.1 Inadequate dental insurance reimbursements and high cost of dental services 52
5.2.2.2 Dearth of trained dental practitioners 52
5.2.3 OPPORTUNITIES 53
5.2.3.1 Introduction of dental service organizations and consolidation of dental practices 53
5.2.3.2 Growth opportunities in emerging economies 53
5.2.3.3 Increasing popularity of dental tourism in emerging countries 53
5.2.4 CHALLENGES 54
5.2.4.1 Pricing pressure and increased market competition 54
5.2.4.2 Stringent regulatory environment 54
5.3 INDUSTRY TRENDS 55
5.3.1 ADVANCEMENTS IN DIGITAL DENTISTRY 55
5.3.2 INCREASED NUMBER OF MINIMALLY INVASIVE DENTAL PROCEDURES 55
5.4 VALUE CHAIN ANALYSIS 55
5.5 TECHNOLOGY ANALYSIS 57
5.5.1 KEY TECHNOLOGIES 57
5.5.1.1 3D bioprinting 57
5.5.2 COMPLEMENTARY TECHNOLOGIES 57
5.5.2.1 Laser-assisted technology 57
5.5.3 ADJACENT TECHNOLOGIES 58
5.5.3.1 Advanced biomaterials 58
5.6 PORTER’S FIVE FORCES ANALYSIS 58
5.6.1 THREAT OF NEW ENTRANTS 60
5.6.2 THREAT OF SUBSTITUTES 60
5.6.3 BARGAINING POWER OF SUPPLIERS 60
5.6.4 BARGAINING POWER OF BUYERS 60
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 61
5.7 KEY STAKEHOLDERS & BUYING CRITERIA 61
5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS 61
5.7.2 KEY BUYING CRITERIA 62
5.8 REGULATORY LANDSCAPE ANALYSIS 62
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
5.8.2 REGULATORY FRAMEWORK 65
5.8.2.1 North America 65
5.8.2.1.1 US 65
5.8.2.2 Europe 66
5.8.2.3 Asia Pacific 67
5.8.2.3.1 India 67
5.8.2.3.2 China 67
5.8.2.3.3 Japan 67
5.9 PATENT ANALYSIS 67
5.9.1 KEY PATENTS GRANTED 69
5.10 TRADE ANALYSIS 70
5.10.1 IMPORT DATA FOR HS CODE 300640 70
5.10.2 EXPORT DATA FOR HS CODE 300640 71
5.11 PRICING ANALYSIS 71
5.11.1 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY KEY PLAYER 72
5.11.2 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY REGION 73
5.12 KEY CONFERENCES & EVENTS, 2024–2025 74
5.13 UNMET NEEDS/END-USER EXPECTATIONS 75
5.14 ADJACENT MARKET ANALYSIS 76
5.15 ECOSYSTEM ANALYSIS 76
5.16 CASE STUDY ANALYSIS 78
5.17 SUPPLY CHAIN ANALYSIS 80
5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81
5.19 INVESTMENT & FUNDING SCENARIO 82
5.20 REIMBURSEMENT SCENARIO ANALYSIS 82
5.21 IMPACT OF AI/GEN AI ON DENTAL SOFT-TISSUE REGENERATION MARKET 83
5.22 PREVALENCE OF GINGIVAL DISEASES, BY KEY REGION, 2023 84
5.23 TOTAL NUMBER OF SURGERIES, BY KEY REGION, 2023 84
6 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE 85
6.1 INTRODUCTION 86
6.1.1 COLLAGEN-BASED MEMBRANES 86
6.1.1.1 Potential to enhance dental tissue regeneration to drive market 86
6.1.2 AUTOGRAFTS 87
6.1.2.1 High compatibility and reduced infection risks to drive market 87
6.1.3 SYNTHETIC BIOMATERIALS 88
6.1.3.1 Technological advancements in biomaterials to fuel market growth 88
6.1.4 OTHER PRODUCTS 90
7 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION 92
7.1 INTRODUCTION 93
7.1.1 IMPLANTOLOGY 93
7.1.1.1 Growing need for implant-supported soft-tissue regeneration to drive market 93
7.1.2 PERIODONTOLOGY 94
7.1.2.1 Increasing prevalence of periodontal diseases to favor market growth 94
7.1.3 OTHER APPLICATIONS 95
8 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER 97
8.1 INTRODUCTION 98
8.2 DENTAL HOSPITALS 98
8.2.1 GROWING AWARENESS OF ORAL HEALTH TO BOOST MARKET 98
8.3 DSOS & INDEPENDENT CLINICS 99
8.3.1 ADVANCEMENTS IN DENTAL CARE TO DRIVE DEMAND 99
8.4 ACADEMIC & RESEARCH INSTITUTES 101
8.4.1 DEVELOPMENT OF ADVANCED DENTAL SOLUTIONS TO BOOST MARKET GROWTH 101
9 DENTAL SOFT-TISSUE REGENERATION MARKET, BY REGION 103
9.1 INTRODUCTION 104
9.2 NORTH AMERICA 105
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 105
9.2.2 US 108
9.2.2.1 US to dominate North American dental soft-tissue regeneration market 108
9.2.3 CANADA 110
9.2.3.1 Stringent regulatory compliance to support market growth in Canada 110
9.3 EUROPE 112
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 112
9.3.2 GERMANY 115
9.3.2.1 Germany to dominate dental soft-tissue regeneration market in Europe 115
9.3.3 UK 117
9.3.3.1 Rising number of geriatric patients to drive market 117
9.3.4 FRANCE 119
9.3.4.1 Well-established healthcare system to drive market 119
9.3.5 SPAIN 120
9.3.5.1 Government initiatives for providing dental coverage to support market growth 120
9.3.6 ITALY 122
9.3.6.1 Growing penetration of dental products to drive market growth 122
9.3.7 REST OF EUROPE (ROE) 124
9.4 ASIA PACIFIC 125
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 125
9.4.2 JAPAN 128
9.4.2.1 Rising geriatric population to support market growth 128
9.4.3 CHINA 130
9.4.3.1 Growing geriatric population and increasing per capita income to support market growth 130
9.4.4 INDIA 131
9.4.4.1 Growing dental care sector to fuel market growth 131
9.4.5 AUSTRALIA 133
9.4.5.1 Growing healthcare expenditure to aid market growth 133
9.4.6 SOUTH KOREA 135
9.4.6.1 Well-developed healthcare sector to drive market 135
9.4.7 REST OF ASIA PACIFIC 136
9.5 LATIN AMERICA 138
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 138
9.5.2 BRAZIL 140
9.5.2.1 Brazil to hold largest share in Latin American market 140
9.5.3 MEXICO 141
9.5.3.1 Increasing healthcare infrastructure to propel market growth 141
9.5.4 ARGENTINA 143
9.5.4.1 Advancements in dental technology to spur growth 143
9.5.5 REST OF LATIN AMERICA 145
9.6 MIDDLE EAST & AFRICA 146
9.6.1 GOVERNMENT INITIATIVES FOR INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET GROWTH 146
9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 146
9.7 GCC COUNTRIES 148
9.7.1 RISING DISPOSABLE INCOMES TO DRIVE MARKET GROWTH 148
9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 148
10 COMPETITIVE LANDSCAPE 150
10.1 OVERVIEW 150
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 150
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET 151
10.3 REVENUE ANALYSIS, 2019–2023 152
10.4 MARKET SHARE ANALYSIS, 2023 152
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 155
10.5.1 STARS 155
10.5.2 EMERGING LEADERS 155
10.5.3 PERVASIVE PLAYERS 155
10.5.4 PARTICIPANTS 155
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 157
10.5.5.1 Company footprint 157
10.5.5.2 Product footprint 158
10.5.5.3 Application footprint 159
10.5.5.4 End-user footprint 160
10.5.5.5 Region footprint 161
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 162
10.6.1 PROGRESSIVE COMPANIES 162
10.6.2 RESPONSIVE COMPANIES 162
10.6.3 DYNAMIC COMPANIES 162
10.6.4 STARTING BLOCKS 162
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 164
10.7 BRAND/PRODUCT COMPARISON 166
10.8 R&D EXPENDITURE OF KEY PLAYERS 167
10.9 COMPANY VALUATION & FINANCIAL METRICS 167
10.10 COMPETITIVE SCENARIO 168
10.10.1 PRODUCT LAUNCHES 168
10.10.2 DEALS 169
10.10.3 EXPANSIONS 171
11 COMPANY PROFILES 172
11.1 KEY PLAYERS 172
11.1.1 GEISTLICH PHARMA AG 172
11.1.1.1 Business overview 172
11.1.1.2 Products offered 172
11.1.1.3 Recent developments 173
11.1.1.3.1 Deals 173
11.1.1.3.2 Expansions 173
11.1.1.4 MnM view 173
11.1.1.4.1 Right to win 173
11.1.1.4.2 Strategic choices 173
11.1.1.4.3 Weaknesses & competitive threats 174
11.1.2 INSTITUT STRAUMANN AG 175
11.1.2.1 Business overview 175
11.1.2.2 Products offered 176
11.1.2.3 MnM view 177
11.1.2.3.1 Right to win 177
11.1.2.3.2 Strategic choices 177
11.1.2.3.3 Weaknesses & competitive threats 177
11.1.3 HENRY SCHEIN, INC. 178
11.1.3.1 Business overview 178
11.1.3.2 Products offered 179
11.1.3.3 Recent developments 180
11.1.3.3.1 Deals 180
11.1.3.4 MnM view 181
11.1.3.4.1 Right to win 181
11.1.3.4.2 Strategic choices 181
11.1.3.4.3 Weaknesses & competitive threats 181
11.1.4 ENVISTA 182
11.1.4.1 Business overview 182
11.1.4.2 Products offered 184
11.1.4.3 Recent developments 184
11.1.4.3.1 Deals 184
11.1.5 ZIMVIE INC. 185
11.1.5.1 Business overview 185
11.1.5.2 Products offered 186
11.1.5.3 Recent developments 187
11.1.5.3.1 Deals 187
11.1.5.4 MnM view 187
11.1.5.4.1 Right to win 187
11.1.5.4.2 Strategic choices 187
11.1.5.4.3 Weaknesses & competitive threats 187
11.1.6 DENTSPLY SIRONA INC. 188
11.1.6.1 Business overview 188
11.1.6.2 Products offered 189
11.1.6.3 Recent developments 190
11.1.6.3.1 Product launches 190
11.1.6.3.2 Deals 190
11.1.6.4 MnM view 190
11.1.6.4.1 Right to win 190
11.1.6.4.2 Strategic choices 190
11.1.6.4.3 Weaknesses & competitive threats 191
11.1.7 ABBVIE INC. 192
11.1.7.1 Business overview 192
11.1.7.2 Products offered 193
11.1.7.3 Recent developments 194
11.1.7.3.1 Expansions 194
11.1.8 ADVANCED MEDICAL SOLUTIONS GROUP PLC 195
11.1.8.1 Business overview 195
11.1.8.2 Products offered 196
11.1.8.3 Recent developments 197
11.1.8.3.1 Deals 197
11.1.9 TISSUE REGENIX 198
11.1.9.1 Business overview 198
11.1.9.2 Products offered 199
11.1.10 SEPTODONT HOLDING 200
11.1.10.1 Business overview 200
11.1.10.2 Products offered 200
11.1.10.3 Recent developments 201
11.1.10.3.1 Deals 201
11.1.11 MEDICAL CONSULT IMPLANTS GMBH 202
11.1.11.1 Business overview 202
11.1.11.2 Products offered 202
11.1.12 MECCELLIS BIOTECH 203
11.1.12.1 Business overview 203
11.1.12.2 Products offered 203
11.1.13 REGEDENT AG 204
11.1.13.1 Business overview 204
11.1.13.2 Products offered 204
11.1.14 REGENITY 205
11.1.14.1 Business overview 205
11.1.14.2 Products offered 205
11.1.14.3 Recent developments 206
11.1.14.3.1 Deals 206
11.1.15 AD SURGICAL 207
11.1.15.1 Business overview 207
11.1.15.2 Products offered 207
11.2 OTHER PLAYERS 208
11.2.1 LIFENET HEALTH 208
11.2.2 B. & B. DENTAL S.R.L. 209
11.2.3 ALPHA-BIO TEC. LTD. 210
11.2.4 LASAK S.R.O. 211
11.2.5 KEYSTONE DENTAL GROUP 212
11.2.6 NEOSS AG 213
11.2.7 BEGO GMBH & CO. KG 214
11.2.8 BIOTECH DENTAL 215
11.2.9 SAMYANG HOLDINGS CORPORATION 216
11.2.10 RTI SURGICAL 217
12 APPENDIX 218
12.1 DISCUSSION GUIDE 218
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 222
12.3 CUSTOMIZATION OPTIONS 224
12.4 RELATED REPORTS 224
12.5 AUTHOR DETAILS 225
LIST OF TABLES
TABLE 1 DENTAL SOFT-TISSUE REGENERATION MARKET: INCLUSIONS & EXCLUSIONS 25
TABLE 2 STANDARD CURRENCY CONVERSION RATES 26
TABLE 3 DENTAL SOFT-TISSUE REGENERATION MARKET: RISK ASSESSMENT 41
TABLE 4 US: AVERAGE SPENDING BY PATIENTS ON COSMETIC DENTISTRY, 2021 VS. 2022 51
TABLE 5 DENTAL SOFT-TISSUE REGENERATION MARKET: PORTER’S FIVE FORCES ANALYSIS 59
TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 61
TABLE 7 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 62
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 63
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 63
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 64
TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 64
TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 65
TABLE 13 DENTAL SOFT-TISSUE REGENERATION MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2022−2024 69
TABLE 14 IMPORT DATA FOR HS CODE 300640, BY COUNTRY,
2019–2023 (USD THOUSAND) 70
TABLE 15 EXPORT DATA FOR HS CODE 300640, BY COUNTRY,
2019–2023 (USD THOUSAND) 71
TABLE 16 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY KEY PLAYER, 2021–2023 (USD) 72
TABLE 17 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY REGION, 2021–2023 (USD) 73
TABLE 18 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY CONFERENCES & EVENTS, JANUARY 2024–DECEMBER 2025 74
TABLE 19 DENTAL SOFT-TISSUE REGENERATION MARKET: UNMET NEEDS 75
TABLE 20 DENTAL SOFT-TISSUE REGENERATION MARKET: ROLE IN ECOSYSTEM 77
TABLE 21 CASE STUDY 1: GUIDED TISSUE REGENERATION BETWEEN NATURAL
TOOTH AND IMPLANT WITH OSSIX PLUS 78
TABLE 22 CASE STUDY 2: ENAMEL MATRIX DERIVATIVE FOR SOFT-TISSUE REGENERATION 79
TABLE 23 CASE STUDY 3: APPLICATION OF HARD- AND SOFT-TISSUE REGENERATIVE APPROACH IN PREDICTABLE MANAGEMENT OF PERI-IMPLANTITIS 79
TABLE 24 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE,
2022–2029 (USD MILLION) 86
TABLE 25 DENTAL SOFT-TISSUE REGENERATION MARKET FOR COLLAGEN-BASED MEMBRANES, BY COUNTRY, 2022–2029 (USD MILLION) 87
TABLE 26 DENTAL SOFT-TISSUE REGENERATION MARKET FOR AUTOGRAFTS,
BY COUNTRY, 2022–2029 (USD MILLION) 88
TABLE 27 DENTAL SOFT-TISSUE REGENERATION MARKET FOR SYNTHETIC BIOMATERIALS, BY COUNTRY, 2022–2029 (USD MILLION) 89
TABLE 28 OTHER DENTAL SOFT-TISSUE REGENERATION PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 91
TABLE 29 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 93
TABLE 30 DENTAL SOFT-TISSUE REGENERATION MARKET FOR IMPLANTOLOGY,
BY COUNTRY, 2022–2029 (USD MILLION) 94
TABLE 31 DENTAL SOFT-TISSUE REGENERATION MARKET FOR PERIODONTOLOGY,
BY COUNTRY, 2022–2029 (USD MILLION) 95
TABLE 32 DENTAL SOFT-TISSUE REGENERATION MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2029 (USD MILLION) 96
TABLE 33 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2022–2029 (USD MILLION) 98
TABLE 34 DENTAL SOFT-TISSUE REGENERATION MARKET FOR DENTAL HOSPITALS,
BY COUNTRY, 2022–2029 (USD MILLION) 99
TABLE 35 DENTAL SOFT-TISSUE REGENERATION FOR DSOS & INDEPENDENT CLINICS,
BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 36 DENTAL SOFT-TISSUE REGENERATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 102
TABLE 37 DENTAL SOFT-TISSUE REGENERATION MARKET, BY REGION,
2022–2029 (USD MILLION) 105
TABLE 38 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 106
TABLE 39 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION) 107
TABLE 40 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 107
TABLE 41 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2022–2029 (USD MILLION) 107
TABLE 42 US: KEY MACROINDICATORS 108
TABLE 43 US: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE,
2022–2029 (USD MILLION) 109
TABLE 44 US: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 109
TABLE 45 US: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2022–2029 (USD MILLION) 109
TABLE 46 CANADA: KEY MACROINDICATORS 110
TABLE 47 CANADA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION) 110
TABLE 48 CANADA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 111
TABLE 49 CANADA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2022–2029 (USD MILLION) 111
TABLE 50 EUROPE DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 114
TABLE 51 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION) 114
TABLE 52 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 114
TABLE 53 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2022–2029 (USD MILLION) 115
TABLE 54 GERMANY: KEY MACROINDICATORS 116
TABLE 55 GERMANY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION) 116
TABLE 56 GERMANY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 116
TABLE 57 GERMANY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2022–2029 (USD MILLION) 117
TABLE 58 UK: KEY MACROINDICATORS 117
TABLE 59 UK: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE,
2022–2029 (USD MILLION) 118
TABLE 60 UK: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 118
TABLE 61 UK: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2022–2029 (USD MILLION) 118
TABLE 62 FRANCE: KEY MACROINDICATORS 119
TABLE 63 FRANCE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION) 119
TABLE 64 FRANCE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 120
TABLE 65 FRANCE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2022–2029 (USD MILLION) 120
TABLE 66 SPAIN: KEY MACROINDICATORS 121
TABLE 67 SPAIN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE,
2022–2029 (USD MILLION) 121
TABLE 68 SPAIN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 121
TABLE 69 SPAIN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2022–2029 (USD MILLION) 122
TABLE 70 ITALY: KEY MACROINDICATORS 122
TABLE 71 ITALY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE,
2022–2029 (USD MILLION) 123
TABLE 72 ITALY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 123
TABLE 73 ITALY: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2022–2029 (USD MILLION) 123
TABLE 74 REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION) 124
TABLE 75 REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 124
TABLE 76 REST OF EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022–2029 (USD MILLION) 125
TABLE 77 ASIA PACIFIC DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 127
TABLE 78 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION) 127
TABLE 79 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 127
TABLE 80 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022–2029 (USD MILLION) 128
TABLE 81 JAPAN: KEY MACROINDICATORS 128
TABLE 82 JAPAN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE,
2022–2029 (USD MILLION) 129
TABLE 83 JAPAN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 129
TABLE 84 JAPAN: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2022–2029 (USD MILLION) 129
TABLE 85 CHINA: KEY MACROINDICATORS 130
TABLE 86 CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE,
2022–2029 (USD MILLION) 130
TABLE 87 CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 131
TABLE 88 CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2022–2029 (USD MILLION) 131
TABLE 89 INDIA: KEY MACROINDICATORS 132
TABLE 90 INDIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE,
2022–2029 (USD MILLION) 132
TABLE 91 INDIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 132
TABLE 92 INDIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2022–2029 (USD MILLION) 133
TABLE 93 AUSTRALIA: KEY MACROINDICATORS 133
TABLE 94 AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION) 134
TABLE 95 AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 134
TABLE 96 AUSTRALIA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2022–2029 (USD MILLION) 134
TABLE 97 SOUTH KOREA: KEY MACROINDICATORS 135
TABLE 98 SOUTH KOREA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION) 135
TABLE 99 SOUTH KOREA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 136
TABLE 100 SOUTH KOREA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022–2029 (USD MILLION) 136
TABLE 101 REST OF ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2022–2029 (USD MILLION) 137
TABLE 102 REST OF ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 137
TABLE 103 REST OF ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2022–2029 (USD MILLION) 137
TABLE 104 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 105 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION) 139
TABLE 106 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 139
TABLE 107 LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2022–2029 (USD MILLION) 139
TABLE 108 BRAZIL: KEY MACROINDICATORS 140
TABLE 109 BRAZIL: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION) 140
TABLE 110 BRAZIL: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 141
TABLE 111 BRAZIL: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2022–2029 (USD MILLION) 141
TABLE 112 MEXICO: KEY MACROINDICATORS 142
TABLE 113 MEXICO: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION) 142
TABLE 114 MEXICO: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 142
TABLE 115 MEXICO: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2022–2029 (USD MILLION) 143
TABLE 116 ARGENTINA: KEY MACROINDICATORS 143
TABLE 117 ARGENTINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION) 144
TABLE 118 ARGENTINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 144
TABLE 119 ARGENTINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022–2029 (USD MILLION) 144
TABLE 120 REST OF LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2022–2029 (USD MILLION) 145
TABLE 121 REST OF LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 145
TABLE 122 REST OF LATIN AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2022–2029 (USD MILLION) 146
TABLE 123 MIDDLE EAST & AFRICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2022–2029 (USD MILLION) 147
TABLE 124 MIDDLE EAST & AFRICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 147
TABLE 125 MIDDLE EAST & AFRICA: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2022–2029 (USD MILLION) 147
TABLE 126 GCC COUNTRIES: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY PRODUCT TYPE, 2022–2029 (USD MILLION) 148
TABLE 127 GCC COUNTRIES: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 149
TABLE 128 GCC COUNTRIES: DENTAL SOFT-TISSUE REGENERATION MARKET,
BY END USER, 2022–2029 (USD MILLION) 149
TABLE 129 DENTAL SOFT-TISSUE REGENERATION MARKET: DEGREE OF COMPETITION 153
TABLE 130 DENTAL SOFT-TISSUE REGENERATION MARKET: PRODUCT FOOTPRINT 158
TABLE 131 DENTAL SOFT-TISSUE REGENERATION MARKET: APPLICATION FOOTPRINT 159
TABLE 132 DENTAL SOFT-TISSUE REGENERATION MARKET: END-USER FOOTPRINT 160
TABLE 133 DENTAL SOFT-TISSUE REGENERATION MARKET: REGION FOOTPRINT 161
TABLE 134 DENTAL SOFT-TISSUE REGENERATION MARKET: DETAILED LIST
OF KEY STARTUPS/SMES 164
TABLE 135 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPETITIVE BENCHMARKING
OF STARTUPS/SMES, BY PRODUCT TYPE 165
TABLE 136 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPETITIVE BENCHMARKING
OF STARTUPS/SMES, BY REGION 165
TABLE 137 DENTAL SOFT-TISSUE REGENERATION MARKET: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024 168
TABLE 138 DENTAL SOFT-TISSUE REGENERATION MARKET: DEALS,
JANUARY 2021–OCTOBER 2024 169
TABLE 139 DENTAL SOFT-TISSUE REGENERATION MARKET: EXPANSIONS,
JANUARY 2021–JUNE 2024 171
TABLE 140 GEISTLICH PHARMA AG: COMPANY OVERVIEW 172
TABLE 141 GEISTLICH PHARMA AG: PRODUCTS OFFERED 172
TABLE 142 GEISTLICH PHARMA AG: DEALS, JANUARY 2021–OCTOBER 2024 173
TABLE 143 GEISTLICH PHARMA AG: EXPANSIONS, JANUARY 2021–OCTOBER 2024 173
TABLE 144 INSTITUT STRAUMANN AG: COMPANY OVERVIEW 175
TABLE 145 INSTITUT STRAUMANN AG: PRODUCTS OFFERED 176
TABLE 146 HENRY SCHEIN, INC.: COMPANY OVERVIEW 178
TABLE 147 HENRY SCHEIN, INC.: PRODUCTS OFFERED 179
TABLE 148 HENRY SCHEIN, INC.: DEALS, JANUARY 2021–OCTOBER 2024 180
TABLE 149 ENVISTA: COMPANY OVERVIEW 182
TABLE 150 ENVISTA: PRODUCTS OFFERED 184
TABLE 151 ENVISTA: DEALS, JANUARY 2021–OCTOBER 2024 184
TABLE 152 ZIMVIE INC.: COMPANY OVERVIEW 185
TABLE 153 ZIMVIE INC.: PRODUCTS OFFERED 186
TABLE 154 ZIMVIE INC.: DEALS, JANUARY 2021–OCTOBER 2024 187
TABLE 155 DENTSPLY SIRONA INC.: COMPANY OVERVIEW 188
TABLE 156 DENTSPLY SIRONA INC.: PRODUCTS OFFERED 189
TABLE 157 DENTSPLY SIRONA INC.: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024 190
TABLE 158 DENTSPLY SIRONA INC.: DEALS, JANUARY 2021–OCTOBER 2024 190
TABLE 159 ABBVIE INC.: COMPANY OVERVIEW 192
TABLE 160 ABBVIE INC.: PRODUCTS OFFERED 193
TABLE 161 ABBVIE INC.: EXPANSIONS, JANUARY 2021–OCTOBER 2024 194
TABLE 162 ADVANCED MEDICAL SOLUTIONS GROUP PLC: COMPANY OVERVIEW 195
TABLE 163 ADVANCED MEDICAL SOLUTIONS GROUP PLC: PRODUCTS OFFERED 196
TABLE 164 ADVANCED MEDICAL SOLUTIONS GROUP PLC: DEALS,
JANUARY 2021–OCTOBER 2024 197
TABLE 165 TISSUE REGENIX: COMPANY OVERVIEW 198
TABLE 166 TISSUE REGENIX: PRODUCTS OFFERED 199
TABLE 167 SEPTODONT HOLDING: COMPANY OVERVIEW 200
TABLE 168 SEPTODONT HOLDING: PRODUCTS OFFERED 200
TABLE 169 SEPTODONT HOLDING: DEALS, JANUARY 2021–OCTOBER 2024 201
TABLE 170 MEDICAL CONSULT IMPLANTS GMBH: COMPANY OVERVIEW 202
TABLE 171 MEDICAL CONSULT IMPLANTS GMBH: PRODUCTS OFFERED 202
TABLE 172 MECCELLIS BIOTECH: COMPANY OVERVIEW 203
TABLE 173 MECCELLIS BIOTECH: PRODUCTS OFFERED 203
TABLE 174 REGEDENT AG: COMPANY OVERVIEW 204
TABLE 175 REGEDENT AG: PRODUCTS OFFERED 204
TABLE 176 REGENITY: COMPANY OVERVIEW 205
TABLE 177 REGENITY: PRODUCTS OFFERED 205
TABLE 178 REGENITY: DEALS, JANUARY 2021–OCTOBER 2024 206
TABLE 179 AD SURGICAL: COMPANY OVERVIEW 207
TABLE 180 AD SURGICAL: PRODUCTS OFFERED 207
TABLE 181 LIFENET HEALTH: COMPANY OVERVIEW 208
TABLE 182 B. & B. DENTAL S.R.L.: COMPANY OVERVIEW 209
TABLE 183 ALPHA-BIO TEC. LTD.: COMPANY OVERVIEW 210
TABLE 184 LASAK S.R.O.: COMPANY OVERVIEW 211
TABLE 185 KEYSTONE DENTAL GROUP: COMPANY OVERVIEW 212
TABLE 186 NEOSS AG: COMPANY OVERVIEW 213
TABLE 187 BEGO GMBH & CO. KG: COMPANY OVERVIEW 214
TABLE 188 BIOTECH DENTAL: COMPANY OVERVIEW 215
TABLE 189 SAMYANG HOLDINGS CORPORATION: COMPANY OVERVIEW 216
TABLE 190 RTI SURGICAL: COMPANY OVERVIEW 217
LIST OF FIGURES
FIGURE 1 DENTAL SOFT-TISSUE REGENERATION MARKET: SEGMENTS CONSIDERED 24
FIGURE 2 DENTAL SOFT-TISSUE REGENERATION MARKET: YEARS CONSIDERED 25
FIGURE 3 DENTAL SOFT-TISSUE REGENERATION MARKET: RESEARCH DESIGN 27
FIGURE 4 DENTAL SOFT-TISSUE REGENERATION MARKET:
KEY DATA FROM SECONDARY SOURCES 29
FIGURE 5 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY PRIMARY SOURCES 29
FIGURE 6 DENTAL SOFT-TISSUE REGENERATION MARKET:
KEY DATA FROM PRIMARY SOURCES 30
FIGURE 7 DENTAL SOFT-TISSUE REGENERATION MARKET: KEY INDUSTRY INSIGHTS 31
FIGURE 8 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 31
FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 32
FIGURE 10 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):
BY END USER, DESIGNATION, AND REGION 32
FIGURE 11 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 33
FIGURE 12 REVENUE SHARE ANALYSIS ILLUSTRATION: INSTITUT STRAUMANN AG (2023) 34
FIGURE 13 SUPPLY-SIDE MARKET SIZE ESTIMATION: DENTAL SOFT-TISSUE REGENERATION MARKET (2023) 35
FIGURE 14 DENTAL SOFT-TISSUE REGENERATION MARKET: TOP-DOWN APPROACH 36
FIGURE 15 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029) 37
FIGURE 16 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38
FIGURE 17 DENTAL SOFT-TISSUE REGENERATION MARKET: DATA TRIANGULATION 39
FIGURE 18 DENTAL SOFT-TISSUE REGENERATION MARKET: STUDY ASSUMPTIONS 40
FIGURE 19 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE,
2024 VS. 2029 (USD MILLION) 42
FIGURE 20 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION,
2024 VS. 2029 (USD MILLION) 43
FIGURE 21 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER,
2024 VS. 2029 (USD MILLION) 43
FIGURE 22 DENTAL SOFT-TISSUE REGENERATION MARKET: REGIONAL SNAPSHOT 44
FIGURE 23 RISING PREVALENCE OF PERIODONTAL DISEASES AND GROWING FOCUS ON DENTAL TOURISM IN EMERGING ECONOMIES TO DRIVE MARKET 45
FIGURE 24 REST OF ASIA PACIFIC AND COLLAGEN-BASED MEMBRANES COMMANDED LARGEST MARKET SHARE IN 2023 46
FIGURE 25 NORTH AMERICA TO DOMINATE MARKET FROM 2024 TO 2029 47
FIGURE 26 CHINA TO GROW AT HIGHEST CAGR DURING STUDY PERIOD 47
FIGURE 27 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES
DURING FORECAST PERIOD 48
FIGURE 28 DENTAL SOFT-TISSUE REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
FIGURE 29 DENTAL SOFT-TISSUE REGENERATION MARKET: VALUE CHAIN ANALYSIS 56
FIGURE 30 DENTAL SOFT-TISSUE REGENERATION MARKET: PORTER’S FIVE FORCES ANALYSIS 59
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 61
FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 62
FIGURE 33 NUMBER OF PATENT PUBLISHED, JANUARY 2014–NOVEMBER 2024 68
FIGURE 34 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DENTAL SOFT-TISSUE REGENERATION (JANUARY 2014– NOVEMBER 2024) 68
FIGURE 35 TOP PATENT APPLICANTS, BY JURISDICTION, JANUARY 2014−NOVEMBER 2024 69
FIGURE 36 DENTAL SOFT-TISSUE REGENERATION MARKET: ADJACENT MARKETS 76
FIGURE 37 DENTAL SOFT-TISSUE REGENERATION MARKET: ECOSYSTEM ANALYSIS 77
FIGURE 38 DENTAL SOFT-TISSUE REGENERATION MARKET: SUPPLY CHAIN ANALYSIS 80
FIGURE 39 DENTAL SOFT-TISSUE REGENERATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81
FIGURE 40 DENTAL SOFT-TISSUE REGENERATION MARKET: FUNDING AND NUMBER OF DEALS, 2020–2023 82
FIGURE 41 DENTAL SOFT-TISSUE REGENERATION MARKET: IMPACT OF AI/GEN AI 83
FIGURE 42 DENTAL SOFT-TISSUE REGENERATION MARKET: GEOGRAPHIC SNAPSHOT 104
FIGURE 43 NORTH AMERICA: DENTAL SOFT-TISSUE REGENERATION MARKET SNAPSHOT 106
FIGURE 44 EUROPE: DENTAL SOFT-TISSUE REGENERATION MARKET SNAPSHOT 113
FIGURE 45 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET SNAPSHOT 126
FIGURE 46 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 151
FIGURE 47 DENTAL SOFT-TISSUE REGENERATION MARKET: REVENUE ANALYSIS, 2019–2023 152
FIGURE 48 DENTAL SOFT-TISSUE REGENERATION MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2023 153
FIGURE 49 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 156
FIGURE 50 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPANY FOOTPRINT 157
FIGURE 51 DENTAL SOFT-TISSUE REGENERATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 163
FIGURE 52 DENTAL SOFT-TISSUE REGENERATION MARKET: BRAND/PRODUCT COMPARISON 166
FIGURE 53 R&D EXPENDITURE OF KEY PLAYERS, 2022 VS. 2023 167
FIGURE 54 EV/EBITDA OF KEY VENDORS 167
FIGURE 55 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR
STOCK BETA OF KEY VENDORS 168
FIGURE 56 INSTITUT STRAUMANN AG: COMPANY SNAPSHOT (2023) 176
FIGURE 57 HENRY SCHEIN, INC.: COMPANY SNAPSHOT (2023) 179
FIGURE 58 ENVISTA: COMPANY SNAPSHOT (2023) 183
FIGURE 59 ZIMVIE INC.: COMPANY SNAPSHOT (2023) 186
FIGURE 60 DENTSPLY SIRONA INC.: COMPANY SNAPSHOT (2023) 189
FIGURE 61 ABBVIE INC.: COMPANY SNAPSHOT (2023) 193
FIGURE 62 ADVANCED MEDICAL SOLUTIONS GROUP PLC: COMPANY SNAPSHOT (2023) 196
FIGURE 63 TISSUE REGENIX: COMPANY SNAPSHOT (2023) 199
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11